Grifols SA’s board of directors said it won’t recommend that shareholders accept Brookfield Asset Management’s indicative ...

Brookfield Asset Management is considering a €6.45 billion ($6.9 billion) bid for Grifols SA, with the drug maker’s board set ...

Grifols (GRFS) stock falls as Brookfield Asset Management (BAM) considers a $6.9B offer, which has met with opposition from ...

Grifols said on Tuesday that Canadian investment fund Brookfield's potential 6.45 billion euro ($6.8 billion) offer ...

Grifols (GRFS) informs that its board has held an extraordinary meeting this afternoon “without the intervention of the conflicted board ...

Brookfield Asset Management Ltd. is considering a €6.45 billion (US$6.9 billion) bid for Grifols SA, with the drug maker’s ...

Grifols is anticipating a period of strong growth on the back of its recently FDA-approved intravenous immunoglobulin product ...

Mason Capital Management LLC ("Mason"), a registered investment advisor to funds and accounts holding approximately 2.1% of ...

Spanish drug maker Grifols said its board would hold an extraordinary meeting to review Brookfield Capital Partners' offer to take the company private, adding that its transaction committee considers ...

A Spanish court yesterday said it was investigating the US hedge fund Gotham City for allegedly publishing “misleading” ...

A Spanish court yesterday said it was investigating the US hedge fund Gotham City for allegedly publishing “misleading” ...